Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for menopause?

The usefulness of a Cardio Risk Check (cardiovascular risk test) during menopause cannot be fully assessed from the provided context. The context mentions general cardiovascular biomarkers such as LDL, ApoB, Lp(a), CRP, and homocysteine, which are supported by a systematic review for reflecting cardiovascular risk. Menopause increases cardiovascular risk due to hormonal changes (declining estrogen), so such a test could theoretically be beneficial. However, the context emphasizes that single biomarkers are insufficient and results must be interpreted by a doctor. No specific studies on menopause are cited. The test is a consumer product; marketing claims should be separated from evidence. Without direct data on menopause, the utility remains uncertain. Recommendation: consult a physician who can consider individual risk factors.